Cargando…
Novel mutations in U(L)24 and gH rescue efficient infection of an HSV vector retargeted to TrkA
Transductional targeting of herpes simplex virus (HSV)-based gene therapy vectors offers the potential for improved tissue-specific delivery and can be achieved by modification of the viral entry machinery to incorporate ligands that bind the desired cell surface proteins. The interaction of nerve g...
Autores principales: | Marzulli, Marco, Hall, Bonnie L., Zhang, Mingdi, Goins, William F., Cohen, Justus B., Glorioso, Joseph C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384243/ https://www.ncbi.nlm.nih.gov/pubmed/37519407 http://dx.doi.org/10.1016/j.omtm.2023.06.012 |
Ejemplares similares
-
Generation of an Oncolytic Herpes Simplex Viral Vector Completely Retargeted to the GDNF Receptor GFRα1 for Specific Infection of Breast Cancer Cells
por: Hall, Bonnie L., et al.
Publicado: (2020) -
TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023) -
Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies
por: Tuzmen, Ceren, et al.
Publicado: (2020) -
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
por: Jackson, Joseph W., et al.
Publicado: (2021) -
NGF – the TrkA to successful pain treatment
por: Kumar, Vinayak, et al.
Publicado: (2012)